Researchers are developing a monthly monoclonal antibody therapy for the treatment and management of chronic pain. The hope is this new therapy can replace opioids for pain management.
Cognitive behavioral therapy for pain that is supported by artificial intelligence renders the same results as guideline-recommended programs while requiring less clinician time, thus making the option more accessible for patients.
Combining electrical stimulation with sounds that activate the somatosensory cortex could help bring relief to those suffering from chronic pain and other neurological conditions.
People given the impression they had control over the music they heard experienced more pain relief than those who felt as though they had no control over their music exposure.
Centralized sensation, or abnormal pain processing in the brain and spinal cord, may be an important underlying factor complicating the treatment of chronic pain in those with opioid use disorder.
Mindfulness meditation interrupted communication between brain areas involved in processing pain sensations and areas that produce the sense of self. This resulted in reduced pain as individuals lost ownership of the sensation.
Researchers have developed a new implantable device that can "cool" nerves and provide on-demand pain relief for those suffering from neuropathic or chronic pain.
Study reveals 27.8% of pain medications with high abuse potential make it all the way through the development process, compared to only 4.7% of medications with lower potential for abuse.